EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model

Juliana Morelli Lopes Gonçalves João, Jéssica Anastácia Silva Barbosa, Luana Laura Sales da Silva, Silvia Fukuzaki, Elaine Cristina de Campos, Leandro do Nascimento Camargo, Tabata Maruyama Dos Santos, Suellen Karoline Moreira Bezerra, Francine Maria de Almeida, Beatriz Mangueira Saraiva-Romanholo, Fernanda Degobbi Tenorio Quirino Dos Santos Lopes, Camila Ramalho Bonturi und 4 weitere

Frontiers in Pharmacology · 07.05.2024 · 15

DOI: 10.3389/fphar.2024.1282870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.05.2024. Verfasst von Juliana Morelli Lopes Gonçalves João und 15 weiteren Autor:innen. Beteiligte Einrichtung: Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The peptide derived from E. contortisiliquum trypsin inhibitor (Pep-3-EcTI), peptide derived from kallikrein inhibitor isolated from B. bauhinioides (Pep-BbKI), and B. rufa peptide modified from B. bauhinioides (Pep-BrTI) peptides exhibit anti-inflammatory and antioxidant activities, suggesting their potential for treating asthma–chronic obstructive pulmonary disease (COPD) overlap (ACO). We compared the effects of these peptides with dexamethasone (DX) treatment in an ACO model. In this study, 11 groups of male BALB/c mice were pre-treated under different conditions, including sensitization with intraperitoneal injection and inhalation of ovalbumin (OVA), intratracheal instillation of porcine pancreatic elastase (ELA), sensitization with intraperitoneal injection, and various combinations of peptide treatments with Pep-3-EcTI, Pep-BbKI, Pep-BrTI, dexamethasone, and non-treated controls (SAL-saline). Respiratory system resistance, airway resistance, lung tissue resistance, exhaled nitric oxide, linear mean intercept, immune cell counts in the bronchoalveolar lavage fluid, cytokine expression, extracellular matrix remodeling, and oxidative stress in the airways and alveolar septa were evaluated on day 28. Results showed increased respiratory parameters, inflammatory markers, and tissue remodeling in the ACO group compared to controls. Treatment with the peptides or DX attenuated or reversed these responses, with the peptides showing effectiveness in controlling hyperresponsiveness, inflammation, remodeling, and oxidative stress markers. These peptides demonstrated an efficacy comparable to that of corticosteroids in the ACO model. However, this study highlights the need for further research to assess their safety, mechanisms of action, and potential translation to clinical studies before considering these peptides for human use.

Schlagwörter

Stichwörter der Autor:innen

airway remodelingasthma–chronic obstructive pulmonary disease overlap syndromedexamethasoneinflammationoxidative stressserine proteinase Inhibitors

Autor:innen und Institutionen

  • Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
  • University City of São Paulo, São Paulo, Brazil.
  • Departamento de Bioquímica, Universidade Federal de Sao Paulo (UNIFESP), São Paulo, Brazil.
  • Hospital Sírio-Libanês, São Paulo, Brazil.

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

João, J. M. L. G., Silva Barbosa, J. A., Sales da Silva, L. L., Fukuzaki, S., de Campos, E. C., Camargo, L. D. N., Dos Santos, T. M., Moreira Bezerra, S. K., de Almeida, F. M., Saraiva-Romanholo, B. M., Lopes, F. D. T. Q. D. S., Bonturi, C. R., Righetti, R. F., Oliva, M. L. V., Tibério, I. F. L. C., & Leick, E. A. (2024). Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1282870

Vancouver

João JMLG, Silva Barbosa JA, Sales da Silva LL, Fukuzaki S, de Campos EC, Camargo LDN, et al. Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1282870

BibTeX
@article{Joo2024,
  author = {João, Juliana Morelli Lopes Gonçalves and Silva Barbosa, Jéssica Anastácia and Sales da Silva, Luana Laura and Fukuzaki, Silvia and de Campos, Elaine Cristina and Camargo, Leandro do Nascimento and Dos Santos, Tabata Maruyama and Moreira Bezerra, Suellen Karoline and de Almeida, Francine Maria and Saraiva-Romanholo, Beatriz Mangueira and Lopes, Fernanda Degobbi Tenorio Quirino Dos Santos and Bonturi, Camila Ramalho and Righetti, Renato Fraga and Oliva, Maria Luiza Vilela and Tibério, Iolanda de Fátima Lopes Calvo and Leick, Edna Aparecida},
  title = {Effects of plant protease inhibitors (Pep-3-EcTI, Pep-BbKI, and Pep-BrTI) versus corticosteroids on inflammation, remodeling, and oxidative stress in an asthma–COPD (ACO) model},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1282870}
}
Kostenlos starten →